Jupiter Neurosciences, Inc. (JUNS) Stock Statistics & Valuation Metrics

Jupiter Neurosciences, Inc. has a market cap or net worth of $65.88M. The enterprise value is $133.34M.

Jupiter Neurosciences, Inc. has 33,103,860 shares outstanding. The number of shares has decreased by -2.65% in one year.

Jupiter Neurosciences, Inc.’s return on equity (ROE) is -0.58 and return on invested capital (ROIC) is -70.42%.

The current PE Ratio of Jupiter Neurosciences, Inc. is -126.24. Jupiter Neurosciences, Inc.’s PEG ratio is 0.40.

In the last 12 months, Jupiter Neurosciences, Inc. had revenue of 0.00 and earned -2.44M in profits. Earnings per share was -0.08.

In the last 12 months, operating cash flow was -4.91M and capital expenditures 0.00, giving a free cash flow of -4.91M billion.

Jupiter Neurosciences, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Jupiter Neurosciences, Inc. upcoming earnings date is ―, TBA Not Confirmed.

Jupiter Neurosciences, Inc. as a current ratio of 2.31, with Debt / Equity ratio of -26.57%

In the past 12 months, Jupiter Neurosciences, Inc. has paid 0.00 in taxes.

Jupiter Neurosciences, Inc. EV to EBITDA ratio is -138.93, with an EV/FCF ratio of -77.84.

Jupiter Neurosciences, Inc. has $2.71M in cash and marketable securities with $205.50K in debt, giving a net cash position of -$2.50M billion.

Gross margin is 100.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Jupiter Neurosciences, Inc. is $30.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy